Navigation Links
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
Date:5/7/2008

NGN Capital leads $12 Million in Series A First Tranche Financing

SAN FRANCISCO and NEW YORK, May 7 /PRNewswire/ -- NGN Capital announced today the formation of ACT Biotech Inc., a new company dedicated to developing and commercializing targeted oral cancer drugs. ACT Biotech has entered into a license agreement with Bayer HealthCare LLC for a portfolio of clinical and early stage oncology assets. In conjunction with the agreement, ACT has raised $12 million in the first tranche of a Series A financing led by NGN Capital, New York. The company has also now initiated the syndication process to raise a total of $20 million, expected to be completed in the second quarter of 2008.

Under the terms of the license agreement with Bayer, ACT Biotech has acquired an anti-angiogenic receptor tyrosine kinase inhibitor entering Phase II clinical studies for colorectal cancer, amongst other indications. An additional program in-licensed in this agreement is a first-in-class multi-mode kinase inhibitor in late preclinical stage with application in a variety of cancer types. The company also acquired several additional preclinical stage programs in oncology. As part of the agreement, Bayer will maintain a minority equity stake in ACT Biotech.

Wolf-Dieter Busse, Ph.D., co-founder of Aerovance, who will serve as Chief Executive Officer of ACT Biotech stated, "We are delighted about our strong portfolio and are eager to advance these exciting cancer drug candidates with our seasoned management team of leading experts in cancer drug discovery and clinical development." In addition, the company will continue to cooperate with the Melanoma Therapeutics Foundation, which is a co-founder in ACT Biotech. The new company will be based in San Francisco, California.

"This license agreement allows Bayer to concentrate on its development program for Nexavar and other primary Oncology assets, while ACT will continue the development of promising, earlier clinica
'/>"/>

SOURCE NGN Capital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genetic Engineering and Biotechnology News reports on early ADMET use
2. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
3. PCMA Response to New York Times Article on Biotech Medicine Costs
4. PCMA: Skyrocketing Biotech Prices Challenge Employers, Consumers
5. Rising Australian biotech stars set to connect on the world stage
6. Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
7. VCU Massey Cancer Center to partner with Israeli biotech firm
8. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. R&D Quality Excellence: Proven Tactics Optimize the R&D Quality Organizations of Pharmaceutical and Biotech Industries
11. Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... August 30, 2014 Bringing forth the ... Search announces the Labor Day discount on all ... surely get the complete services related to internet marketing. ... Content Writers, and others do have a deep understanding ... reflects in their work and since the inception, they ...
(Date:8/30/2014)... August 30, 2014 In today’s world, ... increasingly difficult to get. Snoring and sleep apnea (a ... breathing stops) robs people and their bed partners of ... Up to 45% of the population snores and 20 ... apnea. Of these, only 10% have been diagnosed and ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 August 28th, ... shoulder pain in our society and the toll that ... costs, it’s vital that continuing education for physical therapists ... to help physical therapists help others, Hands-On Seminars is ... , Three learning styles are available to ...
(Date:8/30/2014)... McLeod's Sunset Park Auto Service , ... with strong ties to the community celebrates sixty years in ... they have been chosen by The Tampa Tribune’s ... , Tim McLeod’s father, Norris (most know him as ... Although his son, Tim runs the day to day, taking ...
(Date:8/30/2014)... The SI Joint Evaluation and Treatment covers ... energy techniques. Michael P. Reiman PT, DPT, OCS, SCS, ... for the SI Joint. This PT online ... presentation with North American Seminars. , PT ... differential diagnosis approach to a thorough examination of the ...
Breaking Medicine News(10 mins):Health News:Profit By Search Announces Labor Day Discount on SEO Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2
... LONDON, November 19 21st century mums are more likely,to ... issues because,they feel less judged on their parenting skills than ... commissioned by Tixylix found that only 2% of mothers felt,judged ... judged by,their neighbours and other mums at the school gate. ...
... Preliminary data from the IMPACT,study are ... of America,s,annual conference. The purpose of the ... Training") study was to evaluate,whether improvements from ... memory performance and to self-perceived everyday cognition. ...
... ... Hill-Rom, BATESVILLE, Ind., Nov. 19 ... has,selected Singapore as the site for its Asia-Pacific Innovation Center. The,center will ... (R&D) projects for global applications and will become a,center of excellence for ...
... A multinational team of researchers has shown for the first ... a cancerous tumor without actually killing it. , Scientists have ... eradicate cancers, a technique known as immunotherapy. The new findings ... can,t be killed with immune attacks, it may be possible ...
... combat growing healthcare ... will look under the covers of hospital costs and, efficiencies using ... ... ANGELES, Nov. 18 A new benchmarking study was,launched today to measure the ...
... WASHINGTON, Nov. 16 Speaker Nancy Pelosi,will join ... Saturday, November 17, to discuss the State Children,s ... insurance to 10,million children., WHO: Speaker Nancy ... Congressman Charlie Gonzalez (TX-20) Congressman Henry Cuellar ...
Cached Medicine News:Health News:Mums Go Online to Avoid Judgement 2Health News:First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory 2Health News:Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center 2Health News:Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center 3Health News:Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center 4Health News:Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center 5Health News:Immune system can drive cancers into dormant state 2Health News:Immune system can drive cancers into dormant state 3Health News:Immune system can drive cancers into dormant state 4Health News:Global Health Support Service Benchmark Study to Combat Growing Healthcare Costs and Prepare for Likely Health Care Reforms 2
(Date:8/29/2014)... , Aug. 29, 2014 Research and Markets ... Drug Pipeline Insight 2014" report to their offering. ... US is one of the largest segments of pharmaceuticals industry. ... rate, while the available therapies were unable to meet the ... the market for CNS disorder, especially over the past two ...
(Date:8/29/2014)... -- Does your doctor know what you,re smoking?  Chances are, ... to the over 112,000 currently registered patients under ... other roughly 20,300+ active physicians listed with the Colorado Dept ... even though a poll in February 2014 showed 51% of ... it. "With marijuana legalization underway, every doctor ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Desmarres Retractor Size 4...
Desmarres Lid Retractor thin solid blades. Size 2....
Medicine Products: